Bruce Thornton - 19 Jun 2025 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Executive VP and COO
Signature
/s/ Amy Trombly as attorney-in-fact
Issuer symbol
SNOA
Transactions as of
19 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 17:00:10 UTC
Previous filing
03 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thornton Bruce Executive VP and COO C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER /s/ Amy Trombly as attorney-in-fact 20 Jun 2025 0001383288

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Restricted Stock Units Award $0 +13,500 +72% $0.000000 32,191 19 Jun 2025 Common Stock 13,500 $0.000000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2 The RSUs vest on the third anniversary of the grant date, or upon change of control.
F3 The RSUs were awarded and granted to Mr. Thornton for services performed.